Skip to main content
. 2022 Oct 12;2022:1968829. doi: 10.1155/2022/1968829

Figure 4.

Figure 4

Clinical correlation of our model. Notes: (a–b) univariate and multivariate analysis showed that the model is a risk factor independent of other clinical features; (c) the expression level of MAS1L, TCP10L2, CRHR2, and riskscore in patients with different age groups, ns = P > 0.05; (d) The expression level of MAS1L, TCP10L2, CRHR2, and riskscore in patients with different gender groups, ns = P > 0.05, ∗ = P < 0.05, and ∗∗ = P < 0.01; (e) the expression level of MAS1L, TCP10L2, CRHR2, and riskscore in patients with different stage groups, ns = P > 0.05 and ∗∗∗ = P < 0.001; (f) the expression level of MAS1L, TCP10L2, CRHR2, and riskscore in patients with different T-stage groups, ns = P > 0.05; (g) the expression level of MAS1L, TCP10L2, CRHR2, and riskscore in patients with different M-stage groups, ns = P > 0.05; (h) the expression level of MAS1L, TCP10L2, CRHR2, and riskscore in patients with different N-stage groups, ∗ = P < 0.05, ∗∗ = P < 0.01, and ∗∗∗ = P < 0.001.